Matrix metalloproteinase-3 (MMP-3) -1612 5A/6A promoter polymorphism in coronary artery disease in Indian population

Indian Journal of Clinical Biochemistry

Volumn 25, Issue 2, 2010, Pages 133-140

  Shalia, Kavita K ^a   Shah, V K ^a   Mashru, M R ^a   Soneji, S L ^a   Vasvani, J B ^a   Payannavar, S ^b   Walvalkar, A ^b   Mokal, R ^a   Mithbawkar, S S ^a   Bootwalla, M ^a   Sadvekar, P ^a   Thakur, P K ^a  

^a Sir Hurkisondas Nurrotumdas Hospital & Research Centre   (India)

^b Rajawadi Hospital   (India)

Author keywords

Coronary artery disease; Matrix metalloproteinase 3; Myocardial infarction; Single nucleotide polymorphism; Stable angina; Unstable angina

Indexed keywords

ACETYLSALICYLIC ACID; ALANINE; ANTIANGINA PECTORIS AGENT; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; FIBRINOLYTIC AGENT; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; STROMELYSIN;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HEART INFARCTION; HISTOPATHOLOGY; HUMAN; HYPERTENSION; INDIAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; POLYMERASE CHAIN REACTION; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS;

ANGINA;

EID: 77955437291     PISSN: 09701915     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12291-010-0025-y     Document Type: Article

References (27)

1. E.M. Mtairag S. Chollet-Martin M. Oudghiri N. Laquay J. Marie-Paule Jean-Baptiste, et al. 2001 Effects of interleukin-10 on monocyte/endothelial cell adhesion and MMP-9/TIMP-1 secretion Cardiovasc Res 49 882 890 10.1016/S0008-6363(00)00287-X (Pubitemid 32178392)
2. J.A. Ardans A. Blum P.R. Mangan S. Wientroub R.O. Cannon 3rd L.M. Wahl 2001 Raloxifene-mediated increase in matrix metalloproteinase-1 production by activated monocytes Arterioscler Thromb Vasc Biol 21 1265 1268 10.1161/hq0801.095083 1:CAS:528:DC%2BD3MXmtVais7g%3D 11498451
3. H.B. Ravn E. Falk 1999 Histopathology of plaque rupture Cardiol Clin 17 263 270 10.1016/S0733-8651(05)70073-4 1:STN:280:DyaK1Mzht1yiuw%3D%3D 10384825 (Pubitemid 29277862)
4. P.K. Shah E. Falk J.J. Badimon A. Fernandez-Ortiz A. Mailhac G. Villareal-Levy, et al. 1995 Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture Circulation 92 1565 1569 1:CAS:528:DyaK2MXot1yit7g%3D 7664441
5. Z.S. Galis G.K. Sukhova M.W. Lark P. Libby 1994 Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques J Clin Invest 94 2493 2503 10.1172/JCI117619 1:CAS:528:DyaK2MXisFWgsrg%3D 7989608
6. J.J. Woessner 1991 Matrix metalloproteinases and their inhibitors in connective tissue remodeling FASEB J 5 2145 2154 1:CAS:528:DyaK3MXisVeiurs%3D 1850705
7. A. Henney P. Wakeley M. Davies K. Foster R. Hembry G. Murphy, et al. 1991 Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization Proc Natl Acad Sci USA 88 8154 8158 10.1073/pnas.88.18.8154 1:CAS:528:DyaK3MXmtVCrtbc%3D 1896464
8. S. Ye G. Watts S. Mandalia S. Humphries A. Henney 1995 Preliminary report: Genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis Br Heart J 73 209 215 10.1136/hrt.73.3.209 1:STN:280:DyaK2M3ksVWqtA%3D%3D 7727178
9. S. Ye P. Eriksson A. Hamsten M. Kurkinen S.E. Humphries A.M. Henney 1996 Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression J Biol Chem 271 13055 13060 10.1074/jbc.271.22.13055 1:CAS:528:DyaK28XjtlGisrg%3D 8662692 (Pubitemid 26175880)
10. G. Ghilardi M.L. Biondi M. DeMonti O. Turri E. Guagnellini R. Scorza 2002 Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with carotid artery stenosis Stroke 33 2408 2412 10.1161/01.STR.0000031929.05665.DA 1:CAS:528:DC%2BD38Xntlanu7g%3D 12364729
11. T.L. Medley B.A. Kingwell C.D. Gatzka P. Pillay T.J. Cole 2003 Matrixmetalloproteinase-3 genotype contributes to age-related aortic stiffening through modulation of gene and protein expression Circ Res 92 1254 1261 10.1161/01.RES.0000076891.24317.CA 1:CAS:528:DC%2BD3sXkt12qtLg%3D 12750310 (Pubitemid 36723654)
12. Enas A Enas, Senthilkumar A. Coronary Artery Disease In Asian Indians: An Update And Review. Int J Cardiol 2002; 1(2). Avalable via http://www.ispub.com/ journal/the-internet-journal-of-cardiology/volume-1-number-2-10/article/ coronary-artery-disease-in-asian-indians-an-update-and-review.html
13. S.A. Miller D.D. Dykes H.F. Polesky 1988 A simple salting out procedure for extracting DNA from human nucleated cells Nucleic Acids Res 16 1215 10.1093/nar/16.3.1215 1:CAS:528:DyaL1cXhsVKlsrs%3D 3344216
14. M. Terashima H. Akita K. Kanazawa N. Inoue S. Yamada K. Ito, et al. 1999 Stromelysin promoter 5A/6A polymorphism is associated with acute myocardial infarction Circulation 99 2717 2719 1:STN:280:DyaK1M3otVClsA%3D%3D 10351963
15. T. Nojiri H. Morita Y. Imai K. Maemura M. Ohno K. Ogasawara, et al. 2003 Genetic variations of matrix metalloproteinase-1 and -3 promoter regions and their associations with susceptibility to myocardial infarction in Japanese Int J Cardiol 92 181 186 10.1016/S0167-5273(03)00100-1 14659851 (Pubitemid 37509980)
16. P.Y. Liu J.H. Chen Y.H. Li H.L. Wu G.Y. Shi 2003 Synergistic effect of stromelysin-1 (matrix metallo-proteinase-3) promoter 5A/6A polymorphism with smoking on the onset of young acute myocardial infarction Thromb Haemost 90 132 139 1:CAS:528:DC%2BD3sXls1Wmu7k%3D 12876636
17. X. Zhou J. Huang J. Chen S. Su R. Chen D. Gu 2004 Haplotype analysis of the matrix metalloproteinase-3 gene and myocardial infarction in a Chinese Han population. The Beijing Atherosclerosis Study Thromb Haemost 92 867 873 1:CAS:528:DC%2BD2cXovVOltro%3D 15467919
18. S. Beyzade S. Zhang Y.K. Wong I.N. Day P. Eriksson S. Ye 2003 Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction J Am Coll Cardiol 41 2130 2137 10.1016/S0735-1097(03)00482-0 1:CAS:528:DC%2BD3sXnvVSqsLg%3D 12821236 (Pubitemid 36724257)
19. Y. Yamada H. Izawa S. Ichihara F. Takatsu H. Ishihara H. Hirayama, et al. 2002 Prediction of the risk of myocardial infarction from polymorphisms in candidate genes N Engl J Med 347 1916 1923 10.1056/NEJMoa021445 1:CAS:528:DC%2BD38XptlOqsbg%3D 12477941 (Pubitemid 35429921)
20. J.S. Kim H.Y. Park J.H. Kwon E.K. Im D. Choi Y. Jang, et al. 2002 The roles of stromelysin-1 and the gelatinase B gene polymorphism in stable angina Yonsei Med J 43 473 481 1:CAS:528:DC%2BD38XnsFOitbk%3D 12205736
21. P.J. Pollanen T. Lehtimaki E. Ilveskoski J. Mikkelsson O.A. Kajander P. Laippala, et al. 2002 Coronary artery calcification is related to functional polymorphism of matrix metalloproteinase 3: the Helsinki Sudden Death Study Atherosclerosis 164 329 335 10.1016/S0021-9150(02)00107-7 1:CAS:528: DC%2BD38XmsVCrtLg%3D 12204805 (Pubitemid 35223084)
22. B. Gao Z.C. Li 2004 Association between serum matrix metalloproteinase-3 concentration and the promoter 5A/6A polymorphism in patients with coronary heart disease Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 16 536 539 1:CAS:528:DC%2BD2MXks1CgsQ%3D%3D 15355616
23. A. Samnegard A. Silveira P. Lundman S. Boquist J. Odeberg J. Hulthe, et al. 2005 Serum matrix metalloproteinase-3 concentration is influenced by MMP-3-1612 5A/6A promoter genotype and associated with myocardial infarction J Int Med 258 411 419 10.1111/j.1365-2796.2005.01561.x 1:STN:280: DC%2BD2Mrmt1Orsg%3D%3D (Pubitemid 41546556)
24. D.M. Braganza M.R. Benett 2001 New insights into atherosclerotic plaque rupture Postgrad Med J 77 94 98 10.1136/pmj.77.904.94 1:STN:280: DC%2BD3M7ptlCjsg%3D%3D 11161074 (Pubitemid 32120977)
25. Y. Noji K. Kajinami M. Kawashiri Y. Todo T. Horita A. Nohara, et al. 2001 Circulating matrix metalloproteinases and their inhibitors in premature coronary atherosclerosis Clin Chem Lab Med 39 380 384 10.1515/CCLM.2001.060 1:CAS:528:DC%2BD3MXlt1Kmsbs%3D 11434385 (Pubitemid 32529917)
26. J.L. Beaudeux P. Giral E. Bruckert M. Bernard M.J. Foglietti M.J. Chapman 2003 Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 as potential markers of carotid atherosclerosis in infraclinical hyperlipidemia Atherosclerosis 169 139 146 10.1016/S0021-9150(03) 00149-7 1:CAS:528:DC%2BD3sXlt1Wnu7c%3D 12860260 (Pubitemid 36830932)
27. A.J. White S.J. Duffy A.S. Walton J.F. Ng G.E. Rice S. Mukherjee, et al. 2007 Matrix metalloproteinase-3 and coronary remodelling: implications for unstable coronary disease Cardiovasc Res 75 813 820 10.1016/j.cardiores.2007.05. 003 1:CAS:528:DC%2BD2sXpt1Srsrs%3D 17543900 (Pubitemid 47238734)